1 «Smarter medicine»: liste Top-5 supplémentaire pour la médecine interne générale en ambulatoire. Trägerschaft «smarter medicine – Choosing Wisely Switzerland»/Organisation responsable «smarter medicine – Choosing Wisely Switerzland». Bull Med Suisses. 2021;102(17):572–3.
2 Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. The Cochrane database of systematic reviews. 2019;1(1):Cd009009.
3 Cornuz J, Auer R, Neuner-Jehle S et al. Recommandations suisses pour le bilan de santé au cabinet médical: prévention et dépistage. Forum Med Suisse. 2015;15(43):974–980.
4 Zosso B, Quinto CB, Neuner-Jehle S, Weil B. La prévention au cabinet médical fondée sur les preuves. PEPra: pour la prévention au cabinet de premier recours. Prim Hosp Care Med Int Gen. 2020;20(12):388–390.
5 Patnode CD, Perdue LA, Rushkin M, O’Connor EA. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Unhealthy Drug Use in Primary Care in Adolescents and Adults, Including Pregnant Persons: Updated Systematic Review for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020.
6 Guirguis-Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL, Thompson JH. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Interventions to Prevent Falls in Community-Dwelling Older Adults: A Systematic Review for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018.
7 Société Suisse de Gynécologie et d’Obstétrique. Avis d’expert No 50. Recommandations pour la prévention du cancer du col de l’utérus. 01.03.2018.
8 Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA: the journal of the American Medical Association. 2018;320(7):674–86.
9 Selby K, Gubelmann R, Lovis A, Bulliard JL, Beigelman-Aubry C, Casutt A, et al. [Lung cancer screening: what can we tell our patients while we await a screening program?]. Revue medicale suisse. 2020;16(713):2086–91.
10 Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA: the journal of the American Medical Association. 2021;325(10):962–70.
11 Office fédéral de la santé publique OFSP. Dépistage du VIH effectué sur l’initiative des médecins. Bull 21. OFSP 2015: 237–41.
12 Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement. JAMA: the journal of the American Medical Association. 2019;321(23):2326-36.
13. Office fédéral de la santé publique, Commission fédérale pour les vaccinations. Plan de vaccination suisse 2020. Directives et recommandations. Berne: Office fédéral de la santé publique, 2020.
14. Cornuz J, Pasche O. Compas: stratégies de prise en charge clinique, médecine interne générale ambulatoire. RMS 2019.
15 Unisanté. Recommandations EviPrev. Texte annexe au tableau EviPrev. https://www.pepra.ch/fr/eviprev/.
16 Patterson R, McNamara E, Tainio M, de Sá TH, Smith AD, Sharp SJ, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. European journal of epidemiology. 2018;33(9):811–29.
17 Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. British journal of cancer. 2013;108(11):2205–40.
18 Cornuz J, Junod N, Pasche O, Guessous I. Dépistage des cancers en pratique clinique: une place privilegiée pour le partage de la décision. Revue medicale suisse. 2010;6(256):1410–4.
19 Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. The Cochrane database of systematic reviews. 2017;4(4):Cd001431.
20. Auer R, Selby K, Bulliard JL, Nichita C, Dorta G, Ducros C, et al. Programme cantonal vaudois de dépistage du cancer colorectal: information et décision partagée. Revue medicale suisse. 2015;11(496):2209–15.
21 Selby K, Auer R, Valerio M, Jichlinski P, Cornuz J. Dépistage du cancer de la prostate: partager avec le patient les incertitudes. Revue medicale suisse. 2015;11(496):2216, 8–20.
22 Unisanté. Aides à la décision. https://www.unisante.ch/fr/centre-medical/professionnels-sante/aides-decision.
23 Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA: the journal of the American Medical Association. 2021;325(19):1965-77.
24 Swiss Cancer Screening. Le dépistage systématique du cancer colorectal en chiffres.
https://www.swisscancerscreening.ch/fr/depistage-du-cancer/colon/depistage-en-chiffres. Consulté le 11.05.21.
25 Dehlavi A, Nichita C, Brondolo VK, Bertolini D, Dorta G. Prévention du cancer colorectal. Revue medicale suisse. 2011;7(307):1704-9.
26 Storni M, Lieberherr R, Kaeser M. Enquête suisse sur la santé 2017. Vue d’ensemble. Office fédéral de la statistique 2018.
https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit.assetdetail.6426300.html.
27 Braun AL, Prati E, Martin Y, Dvorak C, Tal K, Biller-Andorno N, et al. Variation in colorectal cancer testing between primary care physicians: a cross-sectional study in Switzerland. Int J Public Health. 2019.
28 Martin Y, Braun AL, Biller-Andorno N, Bulliard JL, Cornuz J, Selby K, et al. Screening Refusal Associated with Choice of Colorectal Cancer Screening Methods. A Cross-sectional Study Among Swiss Primary Care Physicians. J Gen Intern Med. 2019.
29 Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2016;164(4):279–96.
30 Keating NL, Pace LE. Breast Cancer Screening in 2018: Time for Shared Decision Making. Jama. 2018;319(17):1814-5.
31 Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA internal medicine. 2014;174(3):448–54.
32. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Annals of internal medicine. 2016;164(4):244–55.
33 Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. 2014;370(21):1965–7.
34 Swiss Medical Board. Dépistage systématique par mammographie. Rapport du 15.12.2013.
35 Swiss Cancer Screening. Le dépistage systématique du cancer du sein en chiffres.
https://www.swisscancerscreening.ch/fr/depistage-du-cancer/sein/depistage-en-chiffres. Consulté le 11.05.21.
36 Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA: the journal of the American Medical Association. 2018;319(18):1901–13.
37 Swiss Medical Board. Importance du taux de PSA dans le dépistage précoce du cancer de la prostate. Swiss medical Board 2011.
38 Gasser T, Iselin C, Jichlinksi P et al. Dosage du PSA. Recommandations de la Société suisse d’Urologie (SSU). Forum Med Suisse. 2012;12(06):126–8.
39 Tikkinen KAO, Dahm P, Lytvyn L, Heen AF, Vernooij RWM, Siemieniuk RAC, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline. BMJ. 2018;362:k3581.
40 Andriole GL, Crawford ED, Grubb RL, 3rd, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. Journal of the National Cancer Institute. 2012;104(2):125–32.
41 Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, et al. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer. 2017;123(4):592–9.
42 Martin RM, Donovan JL, Turner EL, Metcalfe C, Young GJ, Walsh EI, et al. Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. JAMA: the journal of the American Medical Association. 2018;319(9):883–95.
43 Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027–35.
44 Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. European urology. 2019;76(1):43–51.
45 Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519.
46 Société suisse de pneumologie. Dépistage précoce du cancer du poumon – bilan et perspectives 2017. Ce qui serait souhaitable et ce qui est faisable. Société suisse de pneumologie 2017.
47 Nicod LP, Soccal PM. Une étape décisive pour le dépistage du cancer pulmonaire. Editorial. Rev Med Suisse 2018; volume 14. 2043–4.
48 de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. The New England journal of medicine. 2020;382(6):503–13.
49 Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA: the journal of the American Medical Association. 2021;325(16):1650–6.
50 Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. Journal of hypertension. 2018;36(12):2284–309.
51 Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Journal of hypertension. 2020;38(6):982–1004.
52 Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garcia FA, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. Jama. 2016;316(19):1997-2007.
53 Rodondi N, Waeber G. Dyslipidémies: comment utiliser les nouvelles recommandations au cabinet medical. Forum Med Suisse. 2018;18:973–4.
54 Nanchen D, Vonnez JL, Selby K, Auer R, Cornuz J. Statines en prévention primaire: comment décider avec le patient? Revue medicale suisse. 2015;11(496):2222–6.
55 Guirguis-Blake JM, Beil TL, Senger CA, Coppola EL. Primary Care Screening for Abdominal Aortic Aneurysm: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama. 2019;322(22):2219–38.
56 Bibbins-Domingo K. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2016;164(12):836–45.
57 Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2018;392(10152):1036–46.
58 Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019.
59 Groupe de travail Lipides et Athérosclérose (GSLA) de la Société Suisse de Cardiologie (SSC). Prévention de l’athérosclérose 2020.
http://www.agla.ch.